Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial

Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial

Background: Nonalcoholic steatohepatitis (NASH) is associated with increased cardiovascular risk and mortality. No US Food and Drug Administration (FDA) approved therapies for NASH are available; clinical trials to date have not yet systematically assessed for changes in cardiovascular risk. This st...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Steven C. Lin, Brandon Ang, Carolyn Hernandez, Ricki Bettencourt, Rashmi Jain, Joanie Salotti, Lisa Richards, Yuko Kono, Archana Bhatt, Hamed Aryafar, Grace Y. Lin, Mark A. Valasek, Claude B. Sirlin, Sharon Brouha, Rohit Loomba
Format:	Article
Sprog:	English
Udgivet:	SAGE Publishing 2016-03-01
Serier:	Therapeutic Advances in Gastroenterology
Online adgang:	https://doi.org/10.1177/1756283X15621232

Lignende værker

Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis
af: Janki Patel, et al.
Udgivet: (2016-09-01)

Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls
af: Niraj S. Patel, et al.
Udgivet: (2013-01-01)

Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease
af: Suzanne R. Sharpton, et al.
Udgivet: (2021-10-01)

Changes in the gut microbiome associated with liver stiffness improvement in nonalcoholic steatohepatitis
af: Suzanne R. Sharpton, et al.
Udgivet: (2022-05-01)

Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis1
af: Rohit Loomba, et al.
Udgivet: (2015-01-01)

What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond?
af: Naim Alkhouri, et al.
Udgivet: (2021-11-01)

Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver disease
af: Veeral Ajmera, et al.
Udgivet: (2022-04-01)

Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis
af: Cyrielle Caussy, et al.
Udgivet: (2020-05-01)

Necroptosis in Nonalcoholic Steatohepatitis
af: Jérémie Gautheron, PhD, et al.
Udgivet: (2015-05-01)

A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
af: Cyrielle Caussy, et al.
Udgivet: (2019-03-01)

Human Nonalcoholic Steatohepatitis on a Chip
af: May S. Freag, et al.
Udgivet: (2021-02-01)

Nonalcoholic Steatohepatitis: An Evolving Diagnosis
af: Brent A Neuschwander-Tetri
Udgivet: (2000-01-01)

Oligonucleotide therapies for nonalcoholic steatohepatitis
af: Sixu Li, et al.
Udgivet: (2024-06-01)

Challenges and opportunities in nonalcoholic steatohepatitis
af: Wang Xiaobo
Udgivet: (2022-08-01)

IMAGING DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS
af: Anca Smaranda Farmazon, et al.
Udgivet: (2018-09-01)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
af: Gopanandan Parthasarathy, et al.
Udgivet: (2020-04-01)

The metabolic basis of nonalcoholic steatohepatitis
af: Manu V. Chakravarthy, et al.
Udgivet: (2020-10-01)

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
af: Magdalena Mazurek, et al.
Udgivet: (2023-02-01)

Orlistat for overweight subjects with nonalcoholic steatohepatitis.
af: Dowman, J, et al.
Udgivet: (2009)

Nonalcoholic Steatohepatitis in Nondiabetic Obese Patients
af: Idilio Zamin, et al.
Udgivet: (2002-01-01)

Uncovered issues in the overview of nonalcoholic steatohepatitis
af: Chia-Chi Wang
Udgivet: (2011-12-01)

Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
af: Mindy C.W. Lam, et al.
Udgivet: (2012-07-01)

The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis
af: Hui Xiang, et al.
Udgivet: (2022-02-01)

Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
af: Seonghwan Hwang, et al.
Udgivet: (2021-10-01)

The regulatory state of nonalcoholic steatohepatitis and metabolism
af: Stephanie O. Omokaro, et al.
Udgivet: (2020-10-01)

Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis
af: S.M. Touhidul Islam, et al.
Udgivet: (2020-09-01)

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
af: Melanie D Beaton
Udgivet: (2012-01-01)

Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
af: Sebastião M.B. Duarte, et al.
Udgivet: (2019-05-01)

Ursodeoxycholic Acid and Atorvastatin in the Treatment of Nonalcoholic Steatohepatitis
af: Murat Kiyici, et al.
Udgivet: (2003-01-01)

Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future
af: S. Gitto, et al.
Udgivet: (2015-01-01)

Nonalcoholic Steatohepatitis in a Patient with Ataxia-Telangiectasia
af: Trinidad Caballero, et al.
Udgivet: (2014-01-01)

Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis
af: Mehmet Yalniz, et al.
Udgivet: (2006-01-01)

A Microphysiological System for Studying Nonalcoholic Steatohepatitis
af: Tomasz Kostrzewski, et al.
Udgivet: (2020-01-01)

Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis
af: Alexa M. Giammarino, et al.
Udgivet: (2022-03-01)

The burden of nonalcoholic steatohepatitis (NASH) in the United States
af: Elliot B. Tapper, et al.
Udgivet: (2023-04-01)

The Detrimental Role of Regulatory T Cells in Nonalcoholic Steatohepatitis
af: Janine Dywicki, et al.
Udgivet: (2022-02-01)

Targeting MRG15 for the treatment of nonalcoholic steatohepatitis
af: Yao Zhang, et al.
Udgivet: (2022-12-01)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
af: Helma P. Cotrim, et al.
Udgivet: (2016-05-01)

Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: Brazilian Survey
af: Venancio Avancini Ferreira Alves, et al.
Udgivet: (2016-08-01)

Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology
af: In Cheol Yoon, et al.
Udgivet: (2019-05-01)